These recent research publications acknowledge A Foundation Building Strength as a research supporter and share the latest progress in Nemaline Myopathy research.

NRAP reduction rescues sarcomere defects in nebulin-related nemaline myopathy, 2023
Jennifer G Casey et al.
Recent advances in nemaline myopathy, 2021
Jenni Laitila, Carina Wallgren-Pettersson
Generation of two isogenic induced pluripotent stem cell lines from a 1-month-old nemaline myopathy patient harbouring a homozygous recessive, 2022
Isabella S. Suleski et al.
NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy, 2022
Natasha Ranu et al.
A cross-sectional study of nemaline myopathy supplementary figures, 2021
Kimberly Amburgey et al.
Triggering typical nemaline myopathy with compound heterozygousnebulin mutations reveals myofilament structural changes as pathomechanism, 2020
Johan Lindqvist et al.
Nebulin nemaline myopathy recapitulated in a compound heterozygous mouse model with both a missense and a nonsense mutation in Neb, 2020
Jenni M. Laitila et al.
Expressing a Z-disk nebulin fragment in nebulin-deficient mouse muscle: effects on muscle structure and function, 2020
Frank Li et al.
Omecamtiv mecarbil lowers the contractile deficit in a mouse model of nebulin-based nemaline myopathy, 2019
Johan Lindqvist et al.
Failure to identify modifiers of NEBULIN-related nemaline myopathy in two pre-clinical models of the disease, 2019
Boyang Qiu et al.
Dysregulation of NRAP degradation by KLHL41 contributes to pathophysiology in nemaline myopathy, 2019
Caroline Jirka et al.
Myostatin Inhibition Using ActRIIB-mFc Does Not Produce Weight Gain or Strength in the Nebulin Conditional KO Mouse, 2018
Jennifer A Tinklenberg et al.
TNNT1 nemaline myopathy: natural history and therapeutic frontier, 2018
Michael D Fox et al.